Search results

• Site visit to Sederma Beauty Actives business in France

  17-18 March 2016: Croda International plc hosted a Capital Markets Event for analysts and investors at its Sederma facility near Versailles, France.

• Procurement and sustainable sourcing

  Using natural resources brings a responsibility to ensure no associated negative social or environmental impacts, and an opportunity to advocate and contribute to positive change.

• Annual Report archive

  Annual reports from previous years.

• Contact media enquiries

  For enquiries, contact media.enquiries@croda.com

• A day in the life of our IT team

  Welcome to a behind-the-scenes look at the world of Information Technology (IT) at Croda.

• Croda launches Beauty of Zero™ to advance sustainable innovation in personal care

  Croda launches Beauty of Zero™, a new programme driving science-backed sustainability initiatives and innovation across the beauty industry.

• Croda announces brand evolution to mark centenary year animation Page Summary Title

  Croda announces brand evolution to mark centenary year animation Page Summary Description

• Shareholder centre

  Useful information for Croda Shareholders.

• Shareholder information

  Keep up to date with shareholder and investor information.

• Our Fundamentals

  We will consider all stakeholders in our ecosystem and adopt best practices in environment, labour and human rights, ethics and sustainable procurement.

• Nature Positive

  By 2030, we will be Nature Positive.

• Share price

  Detailed share charts.

• Safety

  Behavioural and process safety are extremely important for us at Croda, the safety of our employees and neighbours is of paramount importance.

• Regulatory news

  Our most recent announcements to the stock exchange.

• Focusing on D&I in Asia

  Colleagues in Asia have been leading a programme of raising awareness, building an inclusive culture, and driving inclusivity in recruitment.

• Investing in mRNA and gene therapy

  As the core of our lipid systems capability within the Health Care business, Avanti is primarily focused on developing innovative lipid-based products of unparalleled purity to address specific medical challenges that are not resolved by current technology.

• ASD Kaleka Mosaik Initiative Impact Fund

  We are contributing to the first Impact Fund of ASD, developed in partnership with Tides Foundation.

• Investors

  Investor information including financial reporting and events.

• Croda supports Pfizer-BioNTech COVID-19 vaccine

  Avanti, a company we acquired in 2020, has a strong track record in supplying R&D quantities of lipid-based drug delivery technologies to pharmaceutical companies including those developing mRNA drugs.

• Ratings and frameworks

  View our ratings and frameworks which help to shape our sustainability programme.

• Our sustainability leadership

  Discover how Croda are driving deeper impact to create greater value across fewer targets.

• Our Commitment

  Croda is committed to being Climate, Nature, and People Positive by 2030, integrating sustainability into its core practices to positively impact the environment and society for a healthier planet and future generations.

• New frontiers in fragrance and flavours

  Croda acquired international fragrances and flavours company Iberchem in 2020, the largest acquisition in our history and a major move into a market strongly aligned with our business.

• Ethics

  Responsible and ethical behaviour is fundamental to the way we operate at Croda.

• Investor overview

  Croda is a successful global company with 105 operations across 39 countries, a focused Life Sciences and Consumer Care company.

• Policies and procedures

  We operate a range of policies covering all area of our Business to uphold the principles of socially responsible business practices.

• Non-financial performance and reports

  We consider our non-financial metrics to be as important as our financial.

• Our business model

  Our business model is designed to create long-term, sustainable value.

• Governance

  Our Board are responsible for good governance and are committed to the highest standards of corporate governance.

• Why invest in Croda?

  Discover why investing in Croda offers long-term growth, innovation-led performance, and sustainable value across global specialty chemicals markets.

• 2025 Annual Report

  Croda’s 2025 Annual Report allows you to explore our financial performance, strategic progress, sustainability highlights, and innovation driving long-term growth.

• Chairs statement 2025

  A message from the Chair, Danuta Gray, highlighting the company’s performance, strategic progress, governance priorities, and outlook for sustainable growth in the year ahead.

• Chief Executive's Statement 2025

  An overview from Steve Foots, our Chief Executive, outlining the year’s key achievements, business performance, strategic priorities, and future outlook for growth and innovation.

• Key Performance Indicators

  Explore Croda’s key performance indicators for 2025, highlighting progress across financial performance, sustainability and strategic priorities.

• First quarter 2026 sales in line with expectations

  Croda International Plc (“Croda” or the “Group”) today provides an update on its sales performance in the first quarter of 2026 (the three months ended 31 March 2026).

• Croda named Britain’s Most Admired Chemicals Company for the tenth time, extending an exceptional record of sustained peer recognition

  20 January 2026: Croda International Plc has been named Britain’s Most Admired Chemicals Company for the tenth time, highlighting its leadership in smart science and high-performance ingredients.

• Danuta Gray, Chair's Letter 2024

  The Board and shareholders are aligned that the Company’s priorities should be execution and operational delivery to grow earnings and improve returns on invested capital.

• Steve Foots, Group Chief Executive Letter

  We are focused on delivery and modernisation, ensuring rigorous cost discipline and driving operational efficiencies to continue our long record of strong performance.

• Croda unveils Matrixyl® Neolide™, an iconic peptide with smarter delivery

  Croda introduces Matrixyl® Neolide™, an iconic peptide with smarter delivery, designed to maximise performance and unlock new possibilities in advanced skin care.

• Consumer Care business review

  Discover how Consumer Care is reinvigorating Beauty and enabling continued growth in Fragrances & Flavours. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

• Annual Report

  Find our 2023 Annual Report here

• Sustainability Impact Report

  Find our 2023 Sustainability Impact Report here

• Materiality assessment

  Our Materiality Assessment performed a comprehensive value chain assessment, and identified areas of transformative action within the business

• Sustainability Impact Report 2024

  Find our 2024 Sustainability Impact Report here

• Steve Foots, CEO Sustainability Statement 2024

  One of our core philosophies is to take a leadership position in sustainability and innovation in our chosen markets.

• Our strategy

  Our focus on innovation, sustainability and growth ensures that Croda smart science helps our customers meet their own sustainability targets as well as consumer demands.

• Megatrends

  Trends which will influence market demand and growth at Croda, Providing new opportunities and shaping our approach.

• Launch of first report on biotechnology opportunities in the personal care market

  27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by biotechnology.

• Our Purpose

  At Croda, our purpose is to use Smart science to improve lives™ through a values-led culture that shapes our work and partnerships. Our knowledge, passion, and entrepreneurial spirit drive the creation of specialty ingredients trusted by industries and consumers worldwide.

• Biotechnology in Personal Care

  Explore the role of biotechnology in the personal care industry and its potential to become the innovative new toolset of choice in our detailed report.